Viewing nowRosuvastatin Calcium Tablets 10mg
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Eden Pharma Co., Ltd.

MFDS item code 201405416 · Approved 2014.11.20 · Insurance code 628900310
Improvement of dyslipidemia, delay of atherosclerotic progression, and prevention of cardiovascular disease
This medication is used as an adjunctive treatment in patients with primary hypercholesterolemia and mixed dyslipidemia when diet and exercise alone are insufficient for management. It is also used in conjunction with dietary therapy or other lipid-lowering therapies in patients with homozygous familial hypercholesterolemia. It helps effectively lower total cholesterol and LDL-cholesterol levels, thus delaying the progression of atherosclerosis. Particularly, it is suitable for pediatric patients aged 10 to 17 years with high LDL-cholesterol levels despite dietary intervention and is used as an adjunct in the treatment of primary dysbetalipoproteinemia. Additionally, it contributes to reducing the risks of stroke, myocardial infarction, and arterial revascularization procedures in middle-aged and older adults with high-sensitivity C-reactive protein levels. This drug plays an important role in improving cardiovascular health.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), combined dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Before and during treatment with this medicine, patients should follow a standard cholesterol-lowering diet and continue it throughout treatment. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. Adjust the maintenance dose appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 milligrams daily. 3. Elderly: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medicine 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Since systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.
Aged 10 years ~ 17 years: The usual dose range is 5 milligrams ~ 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be individually adjusted according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.
This drug should not be used in certain patients. For example, individuals allergic to any of the components of this drug, patients with severe liver dysfunction, those with muscle disorders, patients with severely impaired kidney function, and pregnant or breastfeeding women should not be administered this medication. Furthermore, high-dose administration is prohibited in patients at high risk for muscle-related disorders, and patients with genetic disorders such as lactose intolerance should also avoid using this drug. Care should be taken when administering this drug to patients with poor liver function or those who consume high amounts of alcohol, and regular liver function tests before and during treatment are recommended. Muscle-related side effects such as myalgia, myopathy, and rhabdomyolysis can occur, although they are rare, so if severe muscle pain or weakness develops, immediate medical consultation and testing are required. Patients who are elderly, have kidney diseases, hypothyroidism, or a family history of muscle disorders are at an increased risk for muscle side effects, thus requiring careful monitoring before and after treatment. This drug may affect liver and kidney function, thus regular monitoring of liver and kidney function is important. The drug may interact with other specific medications, so it is essential to inform healthcare providers about any concomitant medications being taken. Pregnant or breastfeeding women should not use this drug, and women who could become pregnant should use appropriate contraception. In cases of overdose, there is no specific antidote, and treatment according to symptoms along with liver and muscle function tests is necessary. Finally, this drug may rarely cause serious skin reactions; if symptoms such as rashes, swelling, fever, etc. occur, immediately discontinue use and consult a physician. Caution is advised when driving or operating machinery as dizziness may occur.
Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, shortness of breath, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, elevated transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, elevated ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, dysesthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and humidity, so it must be stored in a tightly sealed container. It is important to maintain the storage temperature between 1 to 30 degrees Celsius. Proper storage ensures the efficacy and safety of the drug can be retained over time.
Pink round film-coated tablets
28 tablets/Alu-Alu, 30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Eden Pharma Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.